Market data not licensed for redistribution.

Hanmi Pharm

128940 · KOSPI · Pharmaceuticals Manufacturing

– Previous close pending (official data.go.kr feed not active yet) Live price ↗

Source: Financial Services Commission stock price data (data.go.kr), updated once a day.

Daily price, 1 year

Key statistics

Market cap (KRW bn)–

PER–

PBR–

ROE %14.8

Debt ratio % (liabilities / equity)47

Revenue TTM (KRW bn)1,655.5

Op. profit TTM (KRW bn)323.1

Dividend yield %–

Basis: market cap at …; equity = total equity (consolidated if available) at 2026.06.30; net income = trailing 12 months to 2026.06.30 (consolidated). PER is not shown when TTM net income is negative.

Upcoming risk events

Next 90 days for this company, plus macro events tagged with this ticker or its sector. Not a recommendation.

No scheduled risk events found (last checked 2026-10-30 19:40 KST).

See it in the full calendar →

Annual results (KRW bn)

	2021	2022	2023	2024	2025
Revenue	1,203.2	1,331.5	1,490.9	1,495.5	1,547.5
Operating profit	125.4	158.1	220.7	216.2	257.8
Net income	81.5	101.6	165.4	140.4	187.1

Quarterly results (KRW bn, 3 months)

	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	390.9	361.3	362.3	433.0	392.9	467.2
Operating profit	59.0	60.4	55.1	83.3	53.6	131.1
Net income	44.7	43.0	45.4	54.1	51.1	84.1

Largest shareholder

As of the 2025 annual report: 한미사이언스(주) and related parties hold 50.38% of common shares.

Recent disclosures

Date	Filing	Summary
2026-10-30	IR event 기업설명회(IR)개최(안내공시)		DART original
2026-10-30	Technology licensing / alliance 투자판단관련주요경영사항 (파브리병 치료제(LAGLA) 기술이전 계약 체결)	Hanmi Pharm: Technology licensing / alliance	DART original
2026-10-27	Share cancellation 주식소각결정		DART original
2026-10-27	Preliminary earnings 연결재무제표기준영업(잠정)실적(공정공시)		DART original
2026-10-16	IR event 기업설명회(IR)개최(안내공시)		DART original
2026-10-16	Earnings release date notice 결산실적공시예고(안내공시)		DART original
2026-10-07	Clinical trial / regulatory approval 투자판단관련주요경영사항 (에페오토인젝터주(에페글레나타이드) 식품의약품안전처 품목허가 승인)		DART original
2026-10-06	Insider / major-holder ownership report 임원ㆍ주요주주특정증권등소유상황보고서		DART original
2026-10-02	Insider / major-holder ownership report 주식등의대량보유상황보고서(약식)		DART original
2026-09-29	Other material event (investment-relevant) 투자판단관련주요경영사항		DART original
2026-09-29	Insider / major-holder ownership report 주식등의대량보유상황보고서(일반)		DART original
2026-09-29	Insider / major-holder ownership report 임원ㆍ주요주주특정증권등소유상황보고서		DART original

Past material filings and price reaction (market-adjusted)

Date	Filing type	On the news (vs. market)	Next day (vs. market)	20 days (vs. market)
2026-10-07	Clinical trial / regulatory approval	-1.6%	-6.0%	–
2026-09-29	Other material event (investment-relevant)	-2.4%	+1.3%	–
2026-08-24	Other material event (investment-relevant)	+33.1%	-7.9%	-11.1%
2026-07-28	Treasury-stock disposal	+0.1%	-8.0%	+28.0%
2026-07-28	Preliminary earnings	+0.1%	-8.0%	+28.0%
2026-06-01	Technology licensing / alliance	+16.0%	-9.0%	-23.8%
2026-05-29	Clinical trial / regulatory approval	+16.0%	-9.0%	-23.8%
2026-05-21	Single sales/supply contract	+1.6%	+2.0%	-25.4%
2026-04-30	Preliminary earnings	-1.9%	-6.4%	-20.5%
2026-03-12	Cash/stock dividend decision	+0.1%	+3.5%	-3.9%

For information only, not investment advice. Data may be delayed or inaccurate. Full disclaimer → Data: OpenDART (FSS), stock prices: official previous-day close from the Financial Services Commission (data.go.kr) and FinanceData/marcap history, index data via FinanceDataReader, FX: ECB reference rates, crypto data from Upbit, Bithumb and Binance public APIs.
Market data not licensed for redistribution.
© Crypvu · Crypto market view